The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study

Volume: 31, Issue: 2, Pages: 626 - 633
Published: Feb 1, 2021
Abstract
Background and aim Vascular calcification is an independent risk factor for cardiovascular diseases and all-cause mortality in end stage renal disease, and particularly in hemodialysis patients. Vitamin D deficiency has been shown to be associated with vascular calcification among this category of patients. Cholecalciferol or vitamin D3; the native inactivated 25-hydroxy vitamin D [25(OH)D], has been proposed to have a good impact on vascular...
Paper Details
Title
The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study
Published Date
Feb 1, 2021
Volume
31
Issue
2
Pages
626 - 633
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.